EUVIMEDEUVIMED entdecken
Crossref

Long‐term outcomes of augmentation cystoplasty for neurogenic lower urinary tract dysfunction after spinal cord injury

Ioannis Tsikopoulos, Sarah Knight iD, Marc A Furrer iD, Thomas M Kessler, Prashant Patel iD, Rizwan Hamid, Julian Shah, Richard Nobrega

BJU International · 2026-12 · 138 (6) · 1142-1149

DOI: 10.1111/bju.70464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, online erschienen am 09.10.2026. Verfasst von Ioannis Tsikopoulos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuro-Urology, Royal National Orthopaedic Hospital, London, UK. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Urinary Bladder, Neurogenic, Botulinum Toxins, Type A, Urinary Bladder. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate long‐term urodynamic, clinical, and complication outcomes following augmentation cystoplasty (AC) in patients with spinal cord injury (SCI) and refractory neurogenic lower urinary tract dysfunction (NLUTD), and to assess the role of adjunctive intradetrusor onabotulinumtoxinA injections. Patients and Methods We performed a retrospective cohort study of patients with SCI undergoing AC at a tertiary referral centre between 1988 and 2018. Inclusion required refractory NLUTD with documented urodynamic abnormalities and failure of conservative and minimally invasive therapies. Pre‐ and postoperative outcomes included maximum cystometric capacity (MCC), maximum detrusor pressure (MDP), continence status, recurrent urinary tract infections (rUTIs), vesico‐ureteric reflux (VUR), and complications. A subgroup analysis evaluated outcomes following post‐augmentation intradetrusor onabotulinumtoxinA injections. Statistical comparisons were performed using paired t ‐tests.

Results

A total of 70 patients (47 male, 23 female) were included, with a mean (range) follow‐up of 19 (5–36) years. AC resulted in significant improvements in MCC (155–490 mL; P < 0.001) and MDP (72–19 cmH 2 O; P < 0.001). Continence was achieved in 67% of patients, with a further 24% reporting only occasional leakage. rUTIs and antimuscarinic use decreased postoperatively, and VUR improved in most affected patients. Long‐term complications included urolithiasis in 10%, malignancy in 4% (all adenocarcinoma), and spontaneous perforation in 1.5%. In patients requiring adjunctive botulinum toxin ( n = 18), significant improvements in MCC and MDP were observed in selected analyses ( P = 0.025 and P = 0.009, respectively).

Conclusion

Augmentation cystoplasty provides durable long‐term improvements in bladder capacity, storage pressures, and continence in patients with SCI with refractory NLUTD, with sustained protection of the upper urinary tract. Although associated with notable late complications, outcomes remain favourable with structured lifelong surveillance. Adjunctive intradetrusor onabotulinumtoxinA injections offers additional benefit in a subset of patients and may optimise long‐term bladder dynamics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesUrinary Bladder, NeurogenicBotulinum Toxins, Type AUrinary BladderHumansFemaleRetrospective StudiesMaleAdultMiddle AgedTreatment OutcomeUrodynamicsAged

Stichwörter der Autor:innen

augmentation cystoplastybotulinum toxindetrusor–sphincter dyssynergialong‐term outcomesneurogenic detrusor overactivityneurogenic lower urinary tract dysfunctionspinal cord injury

Substanzen

Botulinum Toxins, Type Aonabotulinum toxin A

Autor:innen und Institutionen

  • Department of Neuro-Urology, Royal National Orthopaedic Hospital, London, UK.
  • Department of Urology, University College London Hospital UCLH, London, UK.
  • Department of Urology, Solothurner Spitäler AG, Kantonsspital Olten and Bürgerspital Solothurn, Olten/Solothurn, University of Bern, Bern, Switzerland.
  • Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.

ORCID-Profile: Sarah Knight, Marc A Furrer, Prashant Patel

Zitieren

APA

Tsikopoulos, I., Knight, S., Furrer, M. A., Kessler, T. M., Patel, P., Hamid, R., Shah, J., & Nobrega, R. (2026). Long‐term outcomes of augmentation cystoplasty for neurogenic lower urinary tract dysfunction after spinal cord injury. BJU International, 138(6), 1142-1149. https://doi.org/10.1111/bju.70464

Vancouver

Tsikopoulos I, Knight S, Furrer MA, Kessler TM, Patel P, Hamid R, et al. Long‐term outcomes of augmentation cystoplasty for neurogenic lower urinary tract dysfunction after spinal cord injury. BJU International. 2026;138(6):1142-1149. doi:10.1111/bju.70464

BibTeX
@article{Tsikopoulos2026,
  author = {Tsikopoulos, Ioannis and Knight, Sarah and Furrer, Marc A and Kessler, Thomas M and Patel, Prashant and Hamid, Rizwan and Shah, Julian and Nobrega, Richard},
  title = {Long‐term outcomes of augmentation cystoplasty for neurogenic lower urinary tract dysfunction after spinal cord injury},
  journal = {BJU International},
  year = {2026},
  volume = {138},
  number = {6},
  pages = {1142--1149},
  doi = {10.1111/bju.70464}
}
Kostenlos starten →